Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Stopped Lack of continuing review by IRB
Conditions
- Solid Tumor, Adult
- Metastatic Nonsmall Cell Lung Cancer
- Anatomic Stage IV Breast Cancer AJCC v8
- Metastatic Cervical Carcinoma
- Metastatic Ovarian Carcinoma
- Malignant Uterine Neoplasm
- Vulvar Cancer
- Invasive Breast Cancer
- Metastatic Breast Carcinoma
- Prognostic Stage IV Breast Cancer AJCC v8
- Recurrent Breast Carcinoma
- Recurrent Cervical Carcinoma
- Recurrent Lung Non-Small Cell Carcinoma
- Recurrent Ovarian Carcinoma
- Recurrent Vulvar Carcinoma
- Stage IV Cervical Cancer AJCC v8
- Stage IV Lung Cancer AJCC v8
- Stage IV Vulvar Cancer AJCC v8
- Stage IV Ovarian Cancer AJCC v8
- Stage IVA Cervical Cancer AJCC v8
- Stage IVA Lung Cancer AJCC v8
- Stage IVA Ovarian Cancer AJCC v8
- Stage IVA Vulvar Cancer AJCC v8
- Stage IVB Cervical Cancer AJCC v8
- Stage IVB Lung Cancer AJCC v8
- Stage IVB Ovarian Cancer AJCC v8
- Stage IVB Vulvar Cancer AJCC v8
- Vulva Squamous Cell Carcinoma
Interventions
- OTHER: Blood draws
- OTHER: QLQ-CIPN20 Survey
- OTHER: PR-CTCAE Survey
Sponsor
Wake Forest University Health Sciences
Collaborators